Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000020

Options or other derivatives

  • Chief Medical Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Joshi Manher Chief Medical Officer 2026-08-17 Grant or award · Stock Options (Right to Buy) +50,000 50,000 D: show line 1 in the form
Joshi Manher Chief Medical Officer 2026-08-17 Grant or award · Restricted Stock Units +25,000 25,000 D: show line 2 in the form
Loading xslF345X06/form4.xml…